Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

CJC-1295 (without DAC) and Dutasteride Interaction: Monitor | Peptide Database

Can you take CJC-1295 (without DAC) with Dutasteride? Monitor interaction (51% confidence). See pharmacological analysis, organ load, safety flags, and dosing guidance.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Compound Profiles

CJC-1295 (without DAC)

Short-Acting Growth Hormone Releasing Hormone Analog

Binds GHRH receptors on somatotroph cells in the pituitary gland, stimulating cAMP production and physiological GH pulses. The brief 30-minute half-life allows pulsatile release versus prolonged elevation.

Dutasteride

Dual 5-Alpha Reductase Inhibitor | Hair Loss & BPH

Dutasteride competitively inhibits both the Type I and Type II isoforms of the enzyme 5-alpha reductase. Type II is the predominant isoform in the prostate and hair follicles, while Type I is found primarily in the skin, sebaceous glands, and liver.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take CJC-1295 (without DAC) with Dutasteride?

Yes, but with caution. Both CJC-1295 (without DAC) and Dutasteride can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. Regular monitoring is advised.

Is CJC-1295 (without DAC) and Dutasteride safe together?

Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: estrogenic, teratogenic. Monitor accordingly.

What are the interactions between CJC-1295 (without DAC) and Dutasteride?

Both CJC-1295 (without DAC) and Dutasteride can elevate estrogen. Combined estrogenic load increases risk of gynecomastia, water retention, and mood changes. Monitor estradiol levels and consider AI if needed. This assessment has 51% confidence and is inferred from pharmacological mechanism analysis.

How should I time CJC-1295 (without DAC) and Dutasteride?

CJC-1295 (without DAC) has a half-life of 30 minutes - 2 hours and Dutasteride has a half-life of ~5 weeks (extremely long; active metabolite accumulation over months). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected topics

Follow this recovery question